Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Y Wong

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|April 4, 2002
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesW M Wong, B C Y Wong, H Lu, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Gut|July 8, 2005
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyC-K Hui, W W W Cheung, W-Y Au, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongB Xia, H H X Xia, C W Ma, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycinQ Gu, H H-X Xia, W H Wang, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionW M Wong, Q Gu, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest painH H X Xia, K C Lai, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the diseaseW-M Wong, S K Lam, W M Hui, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2003
Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based studyW M Wong, K C Lai, K F Lam, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2004
Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up studyW M Wong, K C Lai, K F Lam, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|April 4, 2002
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesW M Wong, B C Y Wong, H Lu, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Gut|July 8, 2005
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyC-K Hui, W W W Cheung, W-Y Au, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongB Xia, H H X Xia, C W Ma, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycinQ Gu, H H-X Xia, W H Wang, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionW M Wong, Q Gu, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest painH H X Xia, K C Lai, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the diseaseW-M Wong, S K Lam, W M Hui, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2003
Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based studyW M Wong, K C Lai, K F Lam, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2004
Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up studyW M Wong, K C Lai, K F Lam, et al.
Pageof 6